Christopher Fuglesang Net Worth

What's Christopher Fuglesang's mailing address?

Christopher's mailing address filed with the SEC is C/O PANDION THERAPEUTICS, INC., 134 COOLIDGE AVENUE, WATERTOWN, MA, 02472.

Insiders trading at Pandion Therapeutics

Over the last 4 years, insiders at Pandion Therapeutics have traded over $0 worth of Pandion Therapeutics stock and bought 1,743,632 units worth $30,815,954 . The most active insiders traders include Plc Gsk, Capital Management, L.P.Kol... und Daniel J. Becker. On average, Pandion Therapeutics executives and independent directors trade stock every 11 days with the average trade being worth of $9,518,646. The most recent stock trade was executed by Daniel J. Becker on 19 November 2020, trading 197,716 units of PAND stock currently worth $2,989,466.

What does Pandion Therapeutics do?

Pandion Therapeutics executives and stock owners

Pandion Therapeutics executives and other stock owners filed with the SEC include:

• Capital Management, L.P.Kol...,
  
• Nancy Stagliano,
  Director
• Vikas Goyal,
  See Remarks
• Joanne L. Viney,
  See Remarks
• Partners Gp Viii, L.L.C.Pol...,
  
• Rizzuto Carlo,
  Director
• Jill Carroll,
  Director
• Katina Dorton,
  Director
• Donald Frail,
  Director
• Christopher Fuglesang,
  Director
• Gregg Beloff,
  See Remarks
• Alan L Crane,
  Director
• Mitchell Mutz,
  Director
• Eric D Larson,
  Vice President, Finance
• Daniel J. Becker,
  Director
• Rahul Kakkar,
  Chief Executive Officer
• Plc Gsk,
  Director
• John Sundy,
  Chief Medical Officer
• Edward D. Freedman,
  Chief Operating Officer